close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about OKYO Pharma

Recent news which mentions OKYO Pharma

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
Tickers ALPMF ISEE OKYO VTRS
Tags OKYO Pharma XNAS:OKYO
From TheNewswire.com - RSS (Media)
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
Tickers ALPMF ISEE OKYO VTRS
Tags Benzinga ISEE VTRS
From Benzinga
Phase 2 Trials Begin For Promising New Dry Eye Disease Treatment From OKYO Pharma
Tickers OKYO
Tags OKYO Interview OKYO Pharma
From Benzinga
OKYO Pharma Reports First Patient Visit For Phase 2 Trial Of OK-101, To Fulfill One Of The Two Phase 3 Studies Required For FDA Approval If Successful
Tickers OKYO
Tags General Penny Stocks Benzinga
From Benzinga
OKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Disease
Tickers OKYO
Tags General Benzinga Biotech
From Benzinga
OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
Tickers ALDX OCUL OKYO TARS
Tags Benzinga Private Placement OKYO Pharma
From Benzinga
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Tickers ALDX OCUL OKYO TARS
Tags XNAS:OKYO OKYO Pharma
From TheNewswire.com - RSS (Media)
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Tickers ALDX OCUL OKYO TARS
Tags OCUL General Biotech
From Benzinga
OKYO Pharma's Trial Treating Subjects With DED Gets Listed On ClinicalTrials.gov
Tickers OKYO
Tags General Benzinga Biotech
From Benzinga
OKYO Pharma CEO Gary Jacob Discusses The Company's Future Plans
Tags Biotech Benzinga General
From Benzinga
OKYO Pharma's Drug OK-101 Clears Customs in the US; To Be Used In Phase 2, First-In-Human, Clinical Trial For Patients With Dry Eye Disease
Tickers OKYO
Tags General Biotech Benzinga
From Benzinga
Dry Eye Disease Impacts 49 Million Americans And Disproportionately Affects Women, But Current Treatments Aren't Fully Effective – OKYO Pharma's Drug Candidate Could Be The Solution
Tickers ALDX OKYO TARS
Tags XNAS:OKYO OKYO Pharma
From TheNewswire.com - RSS (Media)
Bio-Pharma Company OKYO Pharma Tackles A Common Eye Disease For Which The Current Treatments Aren't Effective Enough
Tickers ALDX OKYO TARS
Tags Small Cap OKYO Pharma Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today